These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 30254071)
1. Methylation-derived Neutrophil-to-Lymphocyte Ratio and Lung Cancer Risk in Heavy Smokers. Grieshober L; Graw S; Barnett MJ; Thornquist MD; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA Cancer Prev Res (Phila); 2018 Nov; 11(11):727-734. PubMed ID: 30254071 [TBL] [Abstract][Full Text] [Related]
2. Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancer. Grieshober L; Graw S; Barnett MJ; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA Cancer Causes Control; 2021 Nov; 32(11):1227-1236. PubMed ID: 34236573 [TBL] [Abstract][Full Text] [Related]
3. DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes. Koestler DC; Usset J; Christensen BC; Marsit CJ; Karagas MR; Kelsey KT; Wiencke JK Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):328-338. PubMed ID: 27965295 [No Abstract] [Full Text] [Related]
4. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Cherniack MG; Brodkin CA; Hammar S J Natl Cancer Inst; 1996 Nov; 88(21):1550-9. PubMed ID: 8901853 [TBL] [Abstract][Full Text] [Related]
5. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335 [TBL] [Abstract][Full Text] [Related]
6. AHRR methylation in heavy smokers: associations with smoking, lung cancer risk, and lung cancer mortality. Grieshober L; Graw S; Barnett MJ; Thornquist MD; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA BMC Cancer; 2020 Sep; 20(1):905. PubMed ID: 32962699 [TBL] [Abstract][Full Text] [Related]
7. Methylation-derived inflammatory measures and lung cancer risk and survival. Zhao N; Ruan M; Koestler DC; Lu J; Salas LA; Kelsey KT; Platz EA; Michaud DS Clin Epigenetics; 2021 Dec; 13(1):222. PubMed ID: 34915912 [TBL] [Abstract][Full Text] [Related]
8. CARET, the beta-carotene and retinol efficacy trial to prevent lung cancer in asbestos-exposed workers and in smokers. Omenn GS; Goodman G; Grizzle J; Thornquist M; Rosenstock L; Barnhart S; Anderson G; Balmes J; Cherniack M; Cone J Anticancer Drugs; 1991 Feb; 2(1):79-86. PubMed ID: 1958856 [TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers. Omenn GS; Goodman G; Thornquist M; Barnhart S; Balmes J; Cherniack M; Cullen M; Glass A; Keogh J; Liu D; Meyskens F; Perloff M; Valanis B; Williams J IARC Sci Publ; 1996; (136):67-85. PubMed ID: 8791118 [No Abstract] [Full Text] [Related]
10. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720 [TBL] [Abstract][Full Text] [Related]
11. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET). Thornquist MD; Omenn GS; Goodman GE; Grizzle JE; Rosenstock L; Barnhart S; Anderson GL; Hammar S; Balmes J; Cherniack M Control Clin Trials; 1993 Aug; 14(4):308-24. PubMed ID: 8365195 [TBL] [Abstract][Full Text] [Related]
12. The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancer. Goodman GE; Thornquist M; Kestin M; Metch B; Anderson G; Omenn GS Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):815-21. PubMed ID: 8896893 [TBL] [Abstract][Full Text] [Related]
13. Assessing the Role of DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio in Rheumatoid Arthritis. Ambatipudi S; Sharp GC; Clarke SLN; Plant D; Tobias JH; Evans DM; Barton A; Relton CL J Immunol Res; 2018; 2018():2624981. PubMed ID: 30186880 [TBL] [Abstract][Full Text] [Related]
14. Carotene and retinol efficacy trial: lung cancer chemoprevention trial in heavy cigarette smokers and asbestos-exposed workers. CARET Coinvestigators and Staff. Goodman GE; Omenn GS Adv Exp Med Biol; 1992; 320():137-40. PubMed ID: 1442278 [No Abstract] [Full Text] [Related]
15. Lobe of origin and histologic type of lung cancer associated with asbestos exposure in the Carotene and Retinol Efficacy Trial (CARET). Brodkin CA; McCullough J; Stover B; Balmes J; Hammar S; Omenn GS; Checkoway H; Barnhart S Am J Ind Med; 1997 Dec; 32(6):582-91. PubMed ID: 9358913 [TBL] [Abstract][Full Text] [Related]
16. Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival. Wiencke JK; Koestler DC; Salas LA; Wiemels JL; Roy RP; Hansen HM; Rice T; McCoy LS; Bracci PM; Molinaro AM; Kelsey KT; Wrensch MR; Christensen BC Clin Epigenetics; 2017; 9():10. PubMed ID: 28184256 [TBL] [Abstract][Full Text] [Related]
17. Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers. Cheng TY; Goodman GE; Thornquist MD; Barnett MJ; Beresford SA; LaCroix AZ; Zheng Y; Neuhouser ML Int J Cancer; 2014 Nov; 135(9):2135-45. PubMed ID: 24622914 [TBL] [Abstract][Full Text] [Related]
18. No dose-dependent increase in fracture risk after long-term exposure to high doses of retinol or beta-carotene. Ambrosini GL; Bremner AP; Reid A; Mackerras D; Alfonso H; Olsen NJ; Musk AW; de Klerk NH Osteoporos Int; 2013 Apr; 24(4):1285-93. PubMed ID: 22986930 [TBL] [Abstract][Full Text] [Related]
19. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers. Omenn GS; Goodman GE; Thornquist MD; Rosenstock L; Barnhart S; Gylys-Colwell I; Metch B; Lund B Cancer Epidemiol Biomarkers Prev; 1993; 2(4):381-7. PubMed ID: 8348062 [TBL] [Abstract][Full Text] [Related]
20. Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial. Cullen MR; Barnett MJ; Balmes JR; Cartmel B; Redlich CA; Brodkin CA; Barnhart S; Rosenstock L; Goodman GE; Hammar SP; Thornquist MD; Omenn GS Am J Epidemiol; 2005 Feb; 161(3):260-70. PubMed ID: 15671258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]